Skip to main content
. 2014 Oct 1;30(5):265–272. doi: 10.1089/gyn.2013.0088

Table 1.

Clinical and Tumor Characteristics in Patients (N=130) with EOC

Characteristic n (%)
Age at time of surgery 59 (26–90)a
<40 years 10 (7.7)
40–59 years 62 (47.7)
60–79 years 44 (33.8)
>79 years 14 (10.8)
Tumor localization
Unilateral—left 60 (46.2)
Unilateral— right 64 (49.2)
Bilateral 6 (4.6)
FIGO stage
Ia 73 (56.2)
Ib 2 (1.5)
Ic 53 (40.8)
IIa 2 (1.5)
Frozen section results
Not performed 42 (32.3)
Benign 5 (3.8)
Borderline 9 (6.9)
At least borderline 15 (11.5)
Malignant 58 (44.6)
Other 1 (0.8)
Histologic cell type
Mucinous 35 (26.9)
Papillary 2 (1.5)
Serous 16 (12.3)
Papillary mucinous 1 (0.8)
Serous papillary 25 (19.2)
Endometrioid 30 (23.1)
Clear-cell 16 (12.3)
Malignant Brenner tumor 1 (0.8)
Undifferentiated carcinoma 2 (1.5)
Adenocarcinoma (not specified further) 2 (1.5)
Tumor grade
I 54 (41.5)
II 41 (31.5)
III 19 (14.6)
Unknown 16 (12.3)
Attendance of gynecologic oncologist
No 81 (68.6)
Yes 22 (18.6)
Gynecologic oncologist (LUMC) 15 (12.7)
Surgical staging performance
Adequate 56 (43.1)
Inadequate 62 (47.7)
Surgical staging not purposed 12 (9.2)
Treatment according to protocol
Yes 75 (57.7)
No 55 (42.3)
a

Numbers indicate median (range).

EOC, early ovarian cancer; FIGO, International Federation of Gynecologic Oncologists; LUMC, Leiden University Medical Center.